Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Drug Metabolism and Bioanalysis Letters
  4. Volume 17, Issue 2
  5. Article
Volume 17, Issue 2
  • ISSN: 2949-6810
  • E-ISSN: 2949-6829

Abstract

Background

Lobeglitazone sulfate is a novel thiazolidinedione drug used for the therapy of type 2 diabetes. Recent pre-clinical studies show that the drug is also effective in attenuating mucus hypersecretion and airway inflammation caused due to ovalbumin-induced asthma.

Objective

This study aimed to develop an accurate, simple, and cost-effective analytical method for the quantification of lobeglitazone sulfate in bulk and pharmaceutical dosage forms by UV spectrophotometric technique.

Methods

The drug was identified by FTIR (ATR) instrument and the method development was performed with methanol as the solvent. In compliance with the ICH Q2(R2) guidelines, all the important validation parameters, such as linearity, accuracy, Limit of Detection (LOD), precision, specificity, Limit of Quantification (LOQ), and robustness were determined.

Results

The maximum absorption wavelength of lobeglitazone sulfate was found to be 248 nm. The linearity range was established from 2-14 μg/mL with a linearity equation of y = 0.0361x + 0.0024 and r2 = 0.9987. The accuracy of the analytical method was found to be in the range of 99.37-100.41%. The precision studies were performed under three subsets of repeatability, intra-day, and inter-day, and the results recorded were within the acceptance limits, ., %RSD (<2%). The developed analytical method's Limit of Detection (LOD) and Limit of Quantification (LOQ) values were 0.07 μg/mL and 0.22 μg/mL, respectively.

Conclusion

The developed analytical method has been found to be valuable in regular quality control analysis of lobeglitazone sulfate in pharmaceutical industries. The adopted approach of the developed method has been found to be facile, accurate, precise, and economical.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/dmbl/10.2174/0118723128319462240614111627
2024-07-08
2025-06-23

  • From This Site

    /content/journals/dmbl/10.2174/0118723128319462240614111627
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SapraA. BhandariP. Diabetes.Treasure Island, FLStatPearls2023
     [Google Scholar]
  2. TaylorR.B. Types of diabetes mellitus.2024Available From: https://www.webmd.com/diabetes/types-of-diabetes-mellitus
  3. KahnC.R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes.Diabetes19944381066108510.2337/diab.43.8.1066 8039601
     [Google Scholar]
  4. UnnikrishnanR. AnjanaR.M. MohanV. Diabetes mellitus and its complications in India.Nat. Rev. Endocrinol.20161235737010.1038/nrendo.2016.53
     [Google Scholar]
  5. AliO. Genetics of type 2 diabetes.World J. Diabetes20134411412310.4239/wjd.v4.i4.114
     [Google Scholar]
  6. DeyL. AtteleA.S. YuanC.S. Alternative therapies for type 2 diabetes.Altern. Med. Rev.2002714558 11896745
     [Google Scholar]
  7. BaeJ. ParkT. KimH. LeeM. ChaB.S. Lobeglitazone: A novel thiazolidinedione for the management of type 2 diabetes mellitus.Diabetes Metab. J.2021457332645336
     [Google Scholar]
  8. Drugbank. Lobeglitazone.2023Available From: https://go.drugbank.com/drugs/DB09198
  9. PubCHem. Lobeglitazone sulfate | C24H26N4O9S2 | CID 15951505.2023Available From: https://pubchem.ncbi.nlm.nih.gov/compound/Lobeglitazone-sulfate
  10. JangJ.Y. BaeH. LeeY.J. ChoiY. Structural basis for the enhanced anti-diabetic efficacy of lobeglitazone on PPARγ.Sci. Rep.201883118274
     [Google Scholar]
  11. Drugbank. Lobeglitazone sulfate. 2023. Available From: https://go.drugbank.com/salts/DBSALT002555
  12. LeeY.H. KimJ.H. KimS.R. JinH.Y. RheeE.J. ChoY.M. Lobeglitazone, a novel thiazolidinedione, improves non-alcoholic fatty liver disease in type 2 diabetes: Its efficacy and predictive factors related to responsiveness.J. Korean Med. Sci.20173216069
     [Google Scholar]
  13. VulichiS.R. KabraA. KumarR. SumanK. RaoC.V. Cruz-MartinsN. Concise perspectives on some synthetic thiazolidine-2,4-dione derivatives and their specific pharmacodynamic aspects.Life Sci.202127111918210.1016/j.lfs.2021.119182 33577851
     [Google Scholar]
  14. TsengC.H. TsengF.H. Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev.201230436840210.1080/10590501.2012.735519 23167631
     [Google Scholar]
  15. YanH. XieH. YingY. LiJ. WangX. XuX. Pioglitazone use in patients with diabetes and risk of bladder cancer: A systematic review and meta-analysis.Cancer Manag. Res.201810116271638
     [Google Scholar]
  16. ChengD. GaoH. LiW. Long-term risk of rosiglitazone on cardiovascular events - a systematic review and meta-analysis.Endokrynol. Pol.2018694381394 29952413
     [Google Scholar]
  17. GangopadhyayK.K. SinghA.K. Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal.Diabetes Metab. Syndr.202317410274710.1016/j.dsx.2023.102747 36966544
     [Google Scholar]
  18. JoshiS.R. DasS. XaviarS. SamajdarS.S. SahaI. SarkarS. MukherjeeS. TripathiS.K. PalJ. ChatterjeeN. Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis.Diabetes Metab. Syndr.202317110270310.1016/j.dsx.2022.102703 36634469
     [Google Scholar]
  19. GulhaneP.D. JawarkarS.G. Bioanalytical method development and validation for determination of lobeglitazone in human plasma.Int. Res. J. Modern Eng. Technol. Sci.20235514
     [Google Scholar]
  20. LeeJ.H. WooY.A. HwangI.C. KimC.Y. KimD.D. ShimC.K. ChungS.J. Quantification of CKD-501, lobeglitazone, in rat plasma using a liquid-chromatography/tandem mass spectrometry method and its applications to pharmacokinetic studies.J. Pharm. Biomed. Anal.200950587287710.1016/j.jpba.2009.06.003 19577404
     [Google Scholar]
  21. KimB. ShinH.S. KimJ.R. LimK.S. YoonS.H. YuK.S. ShinS-G. JangI-J. ChoJ-Y. Quantitative and qualitative analysis of CKD-501, lobeglitazone, in human plasma and urine using LC-MS/MS and its application to a pharmacokinetic study.Chromatographia20127511-1267167710.1007/s10337‑012‑2238‑0
     [Google Scholar]
  22. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Validation Of Analytical Procedures Q2(R2).2022Available From: https://database.ich.org/sites/default/files/ICH_Q2-R2_Document_Step2_Guideline_2022_0324.pdf
  23. AraujoP. Key aspects of analytical method validation and linearity evaluation.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.20098772322242234 18929516
     [Google Scholar]
  24. RaoT.N. Validation of analytical methods.Calibration and Validation of Analytical Methods - A Sampling of Current Approaches201813114110.5772/intechopen.72087
     [Google Scholar]
  25. Guidance document validation of analytical methods indian pharmacopoeia commission.2021Available From: www.ipc.gov.in
  26. SharmaS. JainS. A novel spectrophotometric method development for quantification of desidustat in bulk and pharmaceutical dosage form.Drug Metab. Bioanal. Lett.202316213313910.2174/2949681016666230828150206
     [Google Scholar]
/content/journals/dmbl/10.2174/0118723128319462240614111627
Loading
Quantification of Lobeglitazone Sulfate in Bulk and Tablet Dosage Form by a Validated UV Spectroscopy Method: A New Thiazolidinedione Antidiabetic Drug
Drug Metab. Bioanal. Lett. 17, 49 (2024); https://doi.org/10.2174/0118723128319462240614111627
/content/journals/dmbl/10.2174/0118723128319462240614111627
/content/journals/dmbl/10.2174/0118723128319462240614111627
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): analysis; Lobeglitazone sulfate; method development; type 2 diabetes; UV spectroscopy; validation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test